Bronchiectasis/B-Disease and/O Recurrent/B-Disease Respiratory/I-Disease Infections/I-Disease with/O a/O De/O Novo/O STAT1/B-Gene Gain/B-PosReg -/I-PosReg of/I-PosReg -/I-PosReg Function/I-PosReg Variant/B-Var :/I-Var First/O Case/O in/O Korea/O ./O
Bronchiectasis/O is/O a/O chronic/O disease/O characterized/O by/O airway/O infection/O and/O inflammation/O ,/O leading/O to/O permanent/O dilation/O of/O the/O bronchi/O ./O
Evaluation/O of/O underlying/O etiology/O is/O important/O in/O managing/O young/O bronchiectasis/O patients/O with/O recurrent/O infections/O caused/O by/O unusual/O pathogens/O ./O
The/O signal/O transducer/O and/O activator/O of/O transcription/O 1/O (/O STAT1/O )/O protein/O plays/O a/O key/O role/O in/O STAT/O signaling/O and/O immune/O system/O regulation/O ./O
Heterozygotes/O for/O gain/B-PosReg -/I-PosReg of/I-PosReg -/I-PosReg function/I-PosReg (/O GOF/O )/O alleles/B-Var of/O the/O STAT1/B-Gene gene/O usually/O display/O autosomal/B-Disease dominant/I-Disease chronic/I-Disease mucocutaneous/I-Disease candidiasis/I-Disease (/O CMC/O )/O and/O a/O wide/O range/O of/O clinical/O features/O ,/O such/O as/O bronchiectasis/B-Disease ./O
Here/O ,/O we/O report/O on/O a/O patient/O with/O CMC/O and/O bronchiectasis/O with/O various/O types/O of/O infections/O who/O carried/O a/O pathogenic/O variant/O of/O the/O STAT1/O gene/O ./O
The/O 24-year/O -/O old/O female/O presented/O with/O recurrent/O respiratory/B-Disease bacterial/I-Disease and/I-Disease nontuberculous/I-Disease mycobacterial/I-Disease infections/I-Disease complicated/O by/O severe/O bronchiectasis/B-Disease and/O CMC/B-Disease ./O
Whole/O -/O exome/O sequencing/O revealed/B-Reg a/O c.800C/B-Var >/I-Var T/I-Var (/O p/O ./O Ala267Val/O )/O heterozygous/O mutation/O in/O the/O STAT1/B-Gene gene/O ./O
Further/O analysis/O by/O Sanger/O sequencing/O of/O STAT1/O from/O the/O patient/O and/O her/O parents/O revealed/O the/O patient/O had/O a/O de/O novo/O occurrence/O of/O the/O variant/O ./O
This/O is/O the/O first/O report/O of/O a/O Korean/O patient/O with/O a/O GOF/O pathogenic/O variant/O in/O STAT1/O ./O
Physicians/O should/O be/O aware/O of/O the/O existence/O of/O this/O variant/O as/O a/O genetic/O factor/O associated/O with/O CMC/O and/O bronchiectasis/O complicated/O by/O recurrent/O infection/O ./O
Single/O copy/O //O knock/O -/O in/O models/O of/O ALS/O SOD1/O in/O C./O elegans/O suggest/O loss/O and/O gain/O of/O function/O have/O different/O contributions/O to/O cholinergic/O and/O glutamatergic/O neurodegeneration/O ./O
Mutations/B-Var in/O Cu/O //O Zn/O superoxide/O dismutase/O 1/O (/B-Gene SOD1/I-Gene )/I-Gene lead/B-Reg to/I-Reg Amyotrophic/B-Disease Lateral/I-Disease Sclerosis/I-Disease (/O ALS/O )/O ,/O a/O neurodegenerative/O disease/O that/O disproportionately/O affects/O glutamatergic/O and/O cholinergic/O motor/O neurons/O ./O
Previous/O work/O with/O SOD1/O overexpression/O models/O supports/O a/O role/O for/O SOD1/O toxic/O gain/O of/O function/O in/O ALS/O pathogenesis/O ./O
However/O ,/O the/O impact/O of/O SOD1/O loss/O of/O function/O in/O ALS/O can/O not/O be/O directly/O examined/O in/O overexpression/O models/O ./O
In/O addition/O ,/O overexpression/O may/O obscure/O the/O contribution/O of/O SOD1/O loss/O of/O function/O in/O the/O degeneration/O of/O different/O neuronal/O populations/O ./O
Here/O ,/O we/O report/O the/O first/O single/O -/O copy/O ,/O ALS/O knock/O -/O in/O models/O in/O C./O elegans/O generated/O by/O transposon-/O or/O CRISPR/O //O Cas9-/O mediated/O genome/O editing/O of/O the/O endogenous/O sod-1/O gene/O ./O
Introduction/O of/O ALS/O patient/O amino/O acid/O changes/O A4V/O ,/O H71Y/O ,/O L84V/O ,/O G85R/O or/O G93A/O into/O the/O C./O elegans/O sod-1/O gene/O yielded/O single/O -/O copy/O //O knock/O -/O in/O ALS/O SOD1/O models/O ./O
These/O differ/O from/O previously/O reported/O overexpression/O models/O in/O multiple/O assays/O ./O
In/O single/O -/O copy/O //O knock/O -/O in/O models/O ,/O we/O observed/O differential/O impact/O of/O sod-1/O ALS/O alleles/O on/O glutamatergic/O and/O cholinergic/O neurodegeneration/O ./O
A4V/O ,/O H71Y/O ,/O G85R/O ,/O and/O G93A/O animals/O showed/O increased/O SOD1/O protein/O accumulation/O and/O oxidative/O stress/O induced/O degeneration/O ,/O consistent/O with/O a/O toxic/O gain/O of/O function/O in/O cholinergic/O motor/O neurons/O ./O
By/O contrast/O ,/O H71Y/O ,/O L84V/O ,/O and/O G85R/O lead/O to/O glutamatergic/O neuron/O degeneration/O due/O to/O sod-1/O loss/O of/O function/O after/O oxidative/O stress/O ./O
However/O ,/O dopaminergic/O and/O serotonergic/O neuronal/O populations/O were/O spared/O in/O single/O -/O copy/O ALS/O models/O ,/O suggesting/O a/O neuronal/O -/O subtype/O specificity/O previously/O not/O reported/O in/O invertebrate/O ALS/O SOD1/O models/O ./O
Combined/O ,/O these/O results/O suggest/O that/O knock/O -/O in/O models/O may/O reproduce/O the/O neurotransmitter/O -/O type/O specificity/O of/O ALS/O and/O that/O both/O SOD1/O loss/O and/O gain/O of/O toxic/O function/O differentially/O contribute/O to/O ALS/O pathogenesis/O in/O different/O neuronal/O populations/O ./O
A/O homozygous/O loss/B-NegReg -/I-NegReg of/I-NegReg -/I-NegReg function/I-NegReg mutation/B-Var leading/O to/O CYBC1/B-Gene deficiency/O causes/O chronic/B-Disease granulomatous/I-Disease disease/I-Disease ./O
Mutations/B-Var in/O genes/O encoding/O subunits/O of/O the/O phagocyte/O NADPH/O oxidase/O complex/O are/O recognized/O to/O cause/B-Reg chronic/B-Disease granulomatous/I-Disease disease/I-Disease (/O CGD/O )/O ,/O a/O severe/O primary/O immunodeficiency/O ./O
Here/O we/O describe/O how/O deficiency/O of/O CYBC1/O ,/O a/O previously/O uncharacterized/O protein/O in/O humans/O (/O C17orf62/O )/O ,/O leads/O to/O reduced/O expression/O of/O NADPH/O oxidase/O 's/O main/O subunit/O (/O gp91phox/O )/O and/O results/O in/O CGD/O ./O
Analyzing/O two/O brothers/O diagnosed/O with/O CGD/O we/O identify/O a/O homozygous/O loss/B-NegReg -/I-NegReg of/I-NegReg -/I-NegReg function/I-NegReg mutation/O ,/O p/B-Var ./I-Var Tyr2Ter/I-Var ,/O in/O CYBC1/B-Gene ./O
Imputation/O of/O p/O ./O Tyr2Ter/O into/O 155/O K/O chip/O -/O genotyped/O Icelanders/O reveals/O six/O additional/O homozygotes/O ,/O all/O with/O signs/O of/O CGD/O ,/O manifesting/O as/O colitis/O ,/O rare/O infections/O ,/O or/O a/O severely/O impaired/O PMA/O -/O induced/O neutrophil/O oxidative/O burst/O ./O
Homozygosity/O for/O p/B-Var ./I-Var Tyr2Ter/I-Var consequently/O associates/B-Reg with/I-Reg inflammatory/B-Disease bowel/I-Disease disease/I-Disease (/O IBD/O )/O in/O Iceland/O (/O P/O =/O 8.3/O ×/O 10/O -/O 8/O ;/O OR/O =/O 67.6/O )/O ,/O as/O well/O as/O reduced/O height/O (/O P/O =/O 3.3/O ×/O 10/O -/O 4/O ;/O -8.5/O cm/O )/O ./O
Overall/O ,/O we/O find/O that/O CYBC1/O deficiency/O results/O in/O CGD/O characterized/O by/O colitis/O and/O a/O distinct/O profile/O of/O infections/O indicative/O of/O macrophage/O dysfunction/O ./O
Loss/O of/O Function/O in/O Zeaxanthin/O Epoxidase/O of/O Dunaliella/O tertiolecta/O Caused/O by/O a/O Single/O Amino/O Acid/O Mutation/O within/O the/O Substrate/O -/O Binding/O Site/O ./O
The/O zea1/O mutant/O of/O marine/O microalga/O Dunaliella/O tertiolecta/O accumulates/O zeaxanthin/O under/O normal/O growth/O conditions/O ,/O and/O its/O phenotype/O has/O been/O speculated/O to/O be/O related/O to/O zeaxanthin/O epoxidase/O (/O ZEP/O )/O ./O
In/O this/O study/O ,/O we/O isolated/O the/O ZEP/O gene/O from/O both/O wild/O -/O type/O D./O tertiolecta/O and/O the/O mutant/O ./O
We/O found/O that/O the/O zea1/O mutant/O has/O a/O point/B-Var mutation/I-Var of/O the/O 1337th/O nucleotide/O of/O the/O ZEP/B-Gene sequence/O (/O a/O change/O from/O guanine/O to/O adenine/O )/O ,/O resulting/O in/O a/O change/B-Reg of/O glycine/B-MPA to/I-MPA aspartate/I-MPA in/I-MPA a/I-MPA highly/I-MPA conserved/I-MPA region/I-MPA in/I-MPA the/I-MPA catalytic/I-MPA domain/I-MPA ./O
Similar/O expression/O levels/O of/O ZEP/O mRNA/O and/O protein/O in/O both/O wild/O -/O type/O and/O zea1/O were/O confirmed/O by/O using/O qRT/O -/O PCR/O and/O western/O blot/O analysis/O ,/O respectively/O ./O
Additionally/O ,/O the/O enzyme/O activity/O analysis/O of/O ZEPs/O in/O the/O presence/O of/O cofactors/O showed/O that/O the/O inactivation/O of/O ZEP/O in/O zea1/O was/O not/O caused/O by/O deficiency/O in/O the/O levels/O of/O cofactors/O ./O
From/O the/O predicted/O three/O -/O dimensional/O ZEP/O structure/O of/O zea1/O ,/O we/O observed/O a/O conformational/O change/O on/O the/O substrate/O -/O binding/O site/O in/O the/O ZEP/O ./O
A/O comparative/O analysis/O of/O the/O ZEP/B-Enzyme structures/O suggested/O that/O the/O conformational/B-MPA change/I-MPA induced/O by/O a/O single/B-Var amino/I-Var acid/I-Var mutation/I-Var might/O impact/B-NegReg the/O interaction/B-Interaction between/I-Interaction the/I-Interaction substrate/I-Interaction and/I-Interaction substrate/I-Interaction -/I-Interaction binding/I-Interaction site/I-Interaction ,/O resulting/O in/O loss/B-NegReg of/O zeaxanthin/B-Enzyme epoxidase/I-Enzyme function/B-MPA ./O
LZTR1/O is/O a/O regulator/O of/O RAS/O ubiquitination/O and/O signaling/O ./O
In/O genetic/O screens/O aimed/O at/O understanding/O drug/O resistance/O mechanisms/O in/O chronic/O myeloid/O leukemia/O cells/O ,/O inactivation/B-Var of/O the/O cullin/O 3/O adapter/O protein/O -/O encoding/O leucine/O zipper/O -/O like/O transcription/O regulator/O 1/O (/B-Gene LZTR1/I-Gene )/I-Gene gene/O led/O to/O enhanced/B-PosReg mitogen/B-Pathway -/I-Pathway activated/I-Pathway protein/I-Pathway kinase/I-Pathway (/I-Pathway MAPK/I-Pathway )/I-Pathway pathway/I-Pathway activity/B-MPA and/O reduced/B-NegReg sensitivity/B-MPA to/I-MPA tyrosine/I-MPA kinase/I-MPA inhibitors/I-MPA ./O
Knockdown/O of/O the/O Drosophila/O LZTR1/O ortholog/O CG3711/O resulted/O in/O a/O Ras/O -/O dependent/O gain/O -/O of/O -/O function/O phenotype/O ./O
Endogenous/O human/O LZTR1/O associates/O with/O the/O main/O RAS/O isoforms/O ./O
Inactivation/B-Var of/O LZTR1/B-Gene led/O to/O decreased/B-NegReg ubiquitination/B-MPA and/O enhanced/B-PosReg plasma/B-MPA membrane/I-MPA localization/I-MPA of/O endogenous/O KRAS/O (/O V/O -/O Ki/O -/O ras2/O Kirsten/O rat/O sarcoma/O viral/O oncogene/O homolog/O )/O ./O
We/O propose/O that/O LZTR1/O acts/O as/O a/O conserved/O regulator/O of/O RAS/O ubiquitination/O and/O MAPK/O pathway/O activation/O ./O
Because/O LZTR1/O disease/O mutations/O failed/O to/O revert/O loss/O -/O of/O -/O function/O phenotypes/O ,/O our/O findings/O provide/O a/O molecular/O rationale/O for/O LZTR1/O involvement/O in/O a/O variety/O of/O inherited/O and/O acquired/O human/O disorders/O ./O
Association/O Between/O Titin/O Loss/O -/O of/O -/O Function/O Variants/O and/O Early/O -/O Onset/O Atrial/O Fibrillation/O ./O
Importance/O :/O Atrial/O fibrillation/O (/O AF/O )/O is/O the/O most/O common/O arrhythmia/O affecting/O 1/O %/O of/O the/O population/O ./O
Young/O individuals/O with/O AF/O have/O a/O strong/O genetic/O association/O with/O the/O disease/O ,/O but/O the/O mechanisms/O remain/O incompletely/O understood/O ./O
Objective/O :/O To/O perform/O large/O -/O scale/O whole/O -/O genome/O sequencing/O to/O identify/O genetic/O variants/O related/O to/O AF/O ./O
Design/O ,/O Setting/O ,/O and/O Participants/O :/O The/O National/O Heart/O ,/O Lung/O ,/O and/O Blood/O Institute/O 's/O Trans/O -/O Omics/O for/O Precision/O Medicine/O Program/O includes/O longitudinal/O and/O cohort/O studies/O that/O underwent/O high/O -/O depth/O whole/O -/O genome/O sequencing/O between/O 2014/O and/O 2017/O in/O 18/O 526/O individuals/O from/O the/O United/O States/O ,/O Mexico/O ,/O Puerto/O Rico/O ,/O Costa/O Rica/O ,/O Barbados/O ,/O and/O Samoa/O ./O
This/O case/O -/O control/O study/O included/O 2781/O patients/O with/O early/O -/O onset/O AF/O from/O 9/O studies/O and/O identified/O 4959/O controls/O of/O European/O ancestry/O from/O the/O remaining/O participants/O ./O
Results/O were/O replicated/O in/O the/O UK/O Biobank/O (/O 346/O 546/O participants/O )/O and/O the/O MyCode/O Study/O (/O 42/O 782/O participants/O )/O ./O
Exposures/O :/O Loss/O -/O of/O -/O function/O (/O LOF/O )/O variants/O in/O genes/O at/O AF/O loci/O and/O common/O genetic/O variation/O across/O the/O whole/O genome/O ./O
Main/O Outcomes/O and/O Measures/O :/O Early/O -/O onset/O AF/O (/O defined/O as/O AF/O onset/O in/O persons/O </O 66/O years/O of/O age/O )/O ./O
Due/O to/O multiple/O testing/O ,/O the/O significance/O threshold/O for/O the/O rare/O variant/O analysis/O was/O P/O =/O 4.55/O ×/O 10/O -/O 3/O ./O
Results/O :/O Among/O 2781/O participants/O with/O early/O -/O onset/O AF/O (/O the/O case/O group/O )/O ,/O 72.1/O %/O were/O men/O ,/O and/O the/O mean/O (/O SD/O )/O age/O of/O AF/O onset/O was/O 48.7/O (/O 10.2/O )/O years/O ./O
Participants/O underwent/O whole/O -/O genome/O sequencing/O at/O a/O mean/O depth/O of/O 37.8/O fold/O and/O mean/O genome/O coverage/O of/O 99.1/O %/O ./O
At/O least/O 1/O LOF/O variant/O in/O TTN/O ,/O the/O gene/O encoding/O the/O sarcomeric/O protein/O titin/O ,/O was/O present/O in/O 2.1/O %/O of/O case/O participants/O compared/O with/O 1.1/O %/O in/O control/O participants/O (/O odds/O ratio/O [/O OR/O ]/O ,/O 1.76/O [/O 95/O %/O CI/O ,/O 1.04/O -/O 2.97/O ]/O )/O ./O
The/O proportion/O of/O individuals/O with/O early/B-Disease -/I-Disease onset/I-Disease AF/I-Disease who/O carried/O a/O LOF/B-PosReg variant/B-Var in/O TTN/B-Gene increased/B-PosReg with/O an/O earlier/O age/O of/O AF/O onset/O (/O P/O value/O for/O trend/O ,/O 4.92/O ×/O 10/O -/O 4/O )/O ,/O and/O 6.5/O %/O of/O individuals/O with/O AF/O onset/O prior/O to/O age/O 30/O carried/O a/O TTN/O LOF/O variant/O (/O OR/O ,/O 5.94/O [/O 95/O %/O CI/O ,/O 2.64/O -/O 13.35/O ]/O ;/O P/O =/O 1.65/O ×/O 10/O -/O 5/O )/O ./O
The/O association/O between/O TTN/O LOF/O variants/O and/O AF/O was/O replicated/O in/O an/O independent/O study/O of/O 1582/O patients/O with/O early/O -/O onset/O AF/O (/O cases/O )/O and/O 41/O 200/O control/O participants/O (/O OR/O ,/O 2.16/O [/O 95/O %/O CI/O ,/O 1.19/O -/O 3.92/O ]/O ;/O P/O =/O .01/O )/O ./O
Conclusions/O and/O Relevance/O :/O In/O a/O case/O -/O control/O study/O ,/O there/O was/O a/O statistically/O significant/B-Reg association/I-Reg between/O an/O LOF/B-NegReg variant/B-Var in/O the/O TTN/B-Gene gene/O and/O early/B-Disease -/I-Disease onset/I-Disease AF/I-Disease ,/O with/O the/O variant/O present/O in/O a/O small/O percentage/O of/O participants/O with/O early/O -/O onset/O AF/O (/O the/O case/O group/O )/O ./O
Further/O research/O is/O necessary/O to/O understand/O whether/O this/O is/O a/O causal/O relationship/O ./O
HDX/O -/O MS/O reveals/O dysregulated/O checkpoints/O that/O compromise/O discrimination/O against/O self/O RNA/O during/O RIG/O -/O I/O mediated/O autoimmunity/O ./O
Retinoic/O acid/O inducible/O gene/O -/O I/O (/O RIG/O -/O I/O )/O ensures/O immune/O surveillance/O of/O viral/O RNAs/O bearing/O a/O 5'-triphosphate/O (/O 5'ppp/O )/O moiety/O ./O
Mutations/O in/O RIG/B-Gene -/I-Gene I/I-Gene (/B-Var C268F/I-Var and/O E373A/B-Var )/I-Var lead/O to/O impaired/B-NegReg ATPase/B-Protein activity/B-MPA ,/O thereby/O driving/O hyperactive/B-PosReg signaling/B-MPA associated/O with/O autoimmune/O diseases/O ./O
Here/O we/O report/O ,/O using/O hydrogen/O //O deuterium/O exchange/O ,/O mechanistic/O models/O for/O dysregulated/O RIG/O -/O I/O proofreading/O that/O ultimately/O result/O in/O the/O improper/O recognition/O of/O cellular/O RNAs/O bearing/O 7-methylguanosine/O and/O N1/O -/O 2'-O/O -/O methylation/O (/O Cap1/O )/O on/O the/O 5/O '/O end/O ./O
Cap1-RNA/O compromises/O its/O ability/O to/O stabilize/O RIG/O -/O I/O helicase/O and/O blunts/O caspase/O activation/O and/O recruitment/O domains/O (/O CARD/O )/O partial/O opening/O by/O threefold/O ./O
RIG/B-Gene -/I-Gene I/I-Gene H830A/B-Var mutation/I-Var restores/B-PosReg Cap1-helicase/B-Protein engagement/B-MPA as/O well/O as/O CARDs/B-MPA partial/I-MPA opening/I-MPA event/I-MPA to/O a/O level/O comparable/O to/O that/O of/O 5'ppp/O ./O
However/O ,/O E373A/B-Var RIG/B-Gene -/I-Gene I/I-Gene locks/O the/O receptor/O in/O an/O ATP/O -/O bound/O state/O ,/O resulting/O in/O enhanced/B-PosReg Cap1-helicase/B-Protein engagement/B-MPA and/O a/O sequential/B-MPA CARDs/I-MPA stimulation/I-MPA ./O
C268F/B-Var mutation/I-Var renders/O a/O more/B-PosReg tethered/B-MPA ring/I-MPA architecture/I-MPA and/O results/B-Reg in/I-Reg constitutive/B-MPA CARDs/I-MPA signaling/I-MPA in/O an/O ATP/O -/O independent/O manner/O ./O
Variant/O Prolactin/O Receptor/O in/O Agalactia/O and/O Hyperprolactinemia/O ./O
A/O loss/O -/O of/O -/O function/O variant/O in/O the/O gene/O encoding/O the/O prolactin/O receptor/O (/O PRLR/O )/O was/O reported/O previously/O in/O a/O woman/O with/O persistent/O postpartum/O galactorrhea/O ;/O however/O ,/O this/O paradoxical/O phenotype/O is/O not/O completely/O understood/O ./O
Here/O we/O describe/O a/O 35-year/O -/O old/O woman/O who/O presented/O with/O idiopathic/O hyperprolactinemia/B-Disease that/O was/O associated/O with/O a/O complete/O lack/O of/O lactation/O after/O each/O of/O her/O two/O deliveries/O ./O
She/O is/O a/O compound/O heterozygote/O for/O loss/B-NegReg -/I-NegReg of/I-NegReg -/I-NegReg function/I-NegReg variants/B-Var of/O PRLR/B-Gene ./O
Her/O unaffected/O parents/O are/O heterozygotes/O ./O
These/O findings/O are/O consistent/O with/O previous/O work/O showing/O that/O mice/O deficient/O in/O functional/O Prlr/O do/O not/B-NegReg lactate/B-CPA ./O
WRKY12/O represses/O GSH1/O expression/O to/O negatively/O regulate/O cadmium/O tolerance/O in/O Arabidopsis/O ./O
KEY/O MESSAGE/O :/O The/O WRKY/O transcription/O factor/O WRKY12/O negatively/O regulates/O Cd/O tolerance/O in/O Arabidopsis/O via/O the/O glutathione/O -/O dependent/O phytochelatin/O synthesis/O pathway/O by/O directly/O targeting/O GSH1/O and/O indirectly/O repressing/O phytochelatin/O synthesis/O -/O related/O gene/O expression/O ./O
Cadmium/O (/O Cd/O )/O is/O a/O widespread/O pollutant/O toxic/O to/O plants/O ./O
The/O glutathione/O (/O GSH)-dependent/O phytochelatin/O (/O PC/O )/O synthesis/O pathway/O plays/O key/O roles/O in/O Cd/O detoxification/O ./O
However/O ,/O its/O regulatory/O mechanism/O remains/O largely/O unknown/O ./O
Here/O ,/O we/O showed/O a/O previously/O unknown/O function/O of/O the/O WRKY/O transcription/O factor/O WRKY12/O in/O the/O regulation/O of/O Cd/O tolerance/O by/O repressing/O the/O expression/O of/O PC/O synthesis/O -/O related/O genes/O ./O
The/O expression/O of/O WRKY12/O was/O inhibited/O by/O Cd/O stress/O ./O
Enhanced/B-PosReg Cd/B-CPA tolerance/I-CPA was/O observed/O in/O the/O WRKY12/B-Gene loss/B-NegReg -/I-NegReg of/I-NegReg -/I-NegReg function/I-NegReg mutants/B-Var ,/O whereas/O increased/O Cd/O sensitivity/O was/O found/O in/O the/O WRKY12-overexpressing/O plants/O ./O
Overexpression/O and/O loss/B-NegReg -/I-NegReg of/I-NegReg -/I-NegReg function/I-NegReg of/O WRKY12/B-Gene were/O associated/O respectively/O with/O increased/O and/O decreased/B-NegReg Cd/B-CPA accumulation/I-CPA by/O repressing/O or/O releasing/B-PosReg the/O expression/B-MPA of/O the/O genes/O involved/O in/O the/O PC/O synthesis/O pathway/O ./O
Transient/O expression/O assay/O showed/O that/O WRKY12/O repressed/O the/O expression/O of/O GSH1/B-Gene ,/O GSH2/B-Gene ,/O PCS1/B-Gene ,/O and/O PCS2/B-Gene ./O
Further/O analysis/O indicated/O that/O WRKY12/O could/O directly/O bind/O to/O the/O W/O -/O box/O of/O the/O promoter/O in/O GSH1/O but/O not/O in/O GSH2/O ,/O PCS1/O ,/O and/O PCS2/O in/O vivo/O ./O
Together/O ,/O our/O results/O suggest/O that/O WRKY12/O directly/O targets/O GSH1/O and/O indirectly/O represses/O PC/O synthesis/O -/O related/O gene/O expression/O to/O negatively/O regulate/O Cd/O accumulation/O and/O tolerance/O in/O Arabidopsis/O ./O
Loss/B-NegReg -/I-NegReg of/I-NegReg -/I-NegReg function/I-NegReg mutations/B-Var in/O QRICH2/B-Gene cause/B-Reg male/B-Disease infertility/I-Disease with/O multiple/O morphological/O abnormalities/O of/O the/O sperm/O flagella/O ./O
Aberrant/B-Var sperm/B-CPA flagella/I-CPA impair/B-NegReg sperm/B-CPA motility/I-CPA and/O cause/B-Reg male/B-Disease infertility/I-Disease ,/O yet/O the/O genes/O which/O have/O been/O identified/O in/O multiple/O morphological/O abnormalities/O of/O the/O flagella/O (/O MMAF/O )/O can/O only/O explain/O the/O pathogenic/O mechanisms/O of/O MMAF/O in/O a/O small/O number/O of/O cases/O ./O
Here/O ,/O we/O identify/O and/O functionally/O characterize/O homozygous/O loss/O -/O of/O -/O function/O mutations/O of/O QRICH2/O in/O two/O infertile/O males/O with/O MMAF/O from/O two/O consanguineous/O families/O ./O
Remarkably/O ,/O Qrich2/O knock/O -/O out/O (/O KO/O )/O male/O mice/O constructed/O by/O CRISPR/O -/O Cas9/O technology/O present/O MMAF/O phenotypes/O and/O sterility/O ./O
To/O elucidate/O the/O mechanisms/O of/O Qrich2/O functioning/O in/O sperm/O flagellar/O formation/O ,/O we/O perform/O proteomic/O analysis/O on/O the/O testes/O of/O KO/O and/O wild/O -/O type/O mice/O ./O
Furthermore/O ,/O in/O vitro/O experiments/O indicate/O that/O QRICH2/O is/O involved/O in/O sperm/O flagellar/O development/O through/O stabilizing/O and/O enhancing/O the/O expression/O of/O proteins/O related/O to/O flagellar/O development/O ./O
Our/O findings/O strongly/O suggest/O that/O the/O genetic/O mutations/B-Var of/O human/O QRICH2/B-Gene can/O lead/B-Reg to/I-Reg male/B-Disease infertility/I-Disease with/O MMAF/B-CPA and/O that/O QRICH2/O is/O essential/O for/O sperm/O flagellar/O formation/O ./O
